If yu gɛt ankylosing spondylitis, yu go mɔs no aw i impɔtant fɔ ɛksesaiz wit di mɛrɛsin we yu dɔktɔ gi yu. Dɛn tritmɛnt ya kin ɛp fɔ ridyus yu pen ɛn ɛp yu fɔ pas yu de izi wan. Bɔt sɔntɛnde, dɛn mɛrɛsin ya kin mek yu gɛt smɔl smɔl sayd ɛfɛkt dɛn. Bɔt nɔ wɔri, dis nɔto so fɔ ɔlman. Ɔlman in bɔdi kin ansa di mɛrɛsin difrɛn we. So, i impɔtant fɔ fɛn di rayt mɛrɛsin fɔ yu, wit di smɔl sayd ɛfɛkt dɛn. Tide, wi go tɔk bɔt dɛn mɛrɛsin ya ɛn di bad tin dɛn we kin apin to dɛn.
Fɔs layn mɛrɛsin: NSAID
Dis na di fɔs pen kil we dɔktɔ dɛn kin gi pipul dɛn we gɛt ankylosing spondylitis. Dɛn kɔl dɛn tin ya non-steroidal anti-inflammatory drugs, ɔ NSAID . Yu kin sabi dɛn nem ya: Ibuprofen, Naproxen, Indomethacin, Celecoxib, ɛn ɔda wan dɛn Dis na di mɛrɛsin dɛn we de insay dis kategori.
Dɛn tin ya kin wok mɔ bay we dɛn kin ridyus di inflamɛns ɛn pen na yu jɔyn dɛn. Bɔt dɛn mɛrɛsin ya kin mek sɔm sayd ɛfɛkt dɛn we dɛn tek am bɔku bɔku wan fɔ lɔng tɛm.
Di impɔtant tin na dat nɔto ɔlman kin gɛt dɛn sayd ɛfɛkt ya, ɛn if yu gɛt wan ɔ tu pan dɛn, i impɔtant fɔ tɔk to yu dɔktɔ bɔt dɛn.
| Sayd ɛfɛkt we pɔsin kin gɛt | Lɛ wi lan bɔt dis simpul wan. |
|---|---|
| At bɔn | I kin bi bikɔs di layn we de protɛkt di bɛlɛ de tan. I kin tan lɛk se yu de bɔn na yu chɛst. |
| Gastrik inflameshɔn ɛn ɔlsa | If yu kɔntinyu fɔ yuz dis mɛrɛsin, dat kin mek yu gɛt inflamɛns ɔ smɔl ɔlsa na di bɛlɛ wɔl. |
| Blɔd we de kɔmɔt | Na smɔl tɛm nɔmɔ, ɔlsa na di bɛlɛ kin mek blɔd kɔmɔt insay yu bɔdi. |
| Risk fɔ gɛt at sik | If yu dɔn gɛt at sik, dis mɛrɛsin kin mek yu gɛt at atak ɔ strok smɔl . I impɔtant fɔ tɛl yu dɔktɔ bɔt dis. |
Di mɛrɛsin dɛn we dɛn de yuz tide: Bayolojikal (IL-17 ɛn JAK Inhibitors) .
If NSAID nɔ go du fɔ kɔntrol yu sik dɛn, yu dɔktɔ kin tɛl yu fɔ tek wan spɛshal klas fɔ mɛrɛsin we dɛn kɔl bayolojikal. Dɛn tin ya de wok bay we dɛn de tɔch sɔm patikyula kemikal dɛn na di bɔdi we de mek pɔsin inflamɛns ɛn blok dɛn akshɔn.
IL-17 Inhibitɔ dɛn
Secukinumab (Cosentyx) ɛn Ixekizumab (Taltz) na tu pan dɛn kayn mɛrɛsin ya. Dɛn kin gi dɛn as injɛkshɔn. Pan ɔl we dɛn kin rili wok, dɛn kin gɛt sɔm bad bad tin dɛn.
- Inflammatory Bowel Disease (IBD): Dis mɛrɛsin kin mek sɔm pipul dɛn gɛt nyu IBD ɔ i kin mek di sik wɔs if yu dɔn gɛt am.
- Infɛkshɔn: Bikɔs dɛn mɛrɛsin ya kin gɛt smɔl ifɛkt pan di bɔdi in imyun sistɛm, di risk fɔ gɛt kɔmɔn infɛkshɔn (lɛk flu ɛn kol) kin go ɔp smɔl.
- Kansa risk: Pan ɔl we di tɛst dɛn we dɛn dɔn du na lɛbɔtri dɔn sho se pɔsin kin gɛt kansa we dɛn gi am to mays, no klia pruf stil de fɔ se i kin gɛt kansa to mɔtalman. Nɔr wɔri bɔt dis wae nɔr nid, yu dɔktɔ go tich yu bɔt dis.
JAK Inhibitɔ dɛn
Tofacitinib (Xeljanz) na wan kayn mɛrɛsin we yu kin tek as pil. I de wok bak bay we i de ridyus di inflamɛns. Sɔm pan di bad tin dɛn we kin apin to am na:
- Ed de at
- Rɔnbɛlɛ
- Taya
- Di at we de blo
- Smɔl risk fɔ mek di liva pwɛl
Mɛrɛsin dɛn we dɛn nɔ kin yuz bɔku tɛm
Sɔntɛnde, dɛn kin ad ɔda mɛrɛsin dɛn bak to yu tritmɛnt plan.
Sterɔyd mɛrɛsin dɛn (Kɔtikosterɔyd) .
Dɛn nɔ kin gi dɛn tin ya fɔ lɔng tɛm tritmɛnt fɔ ankylosing spondylitis. Bɔt if di pen ɛn swel kam tumɔs wantɛm wantɛm, yu dɔktɔ kin gi yu wan stɛroyd injɛkshɔn na di jɔyn we dɔn swel. If yu yuz dɛn mɛrɛsin ya fɔ lɔng tɛm, dat kin mek yu gɛt bɔku bad bad tin dɛn. So, dɛn kin yuz dɛn fɔ shɔt tɛm nɔmɔ, we nid de. Sɔm pan di bad tin dɛn we kin apin to pɔsin na:
- I kin mek pɔsin want fɔ it mɔ ɛn mɔ ɛn i kin gɛt mɔ wet
- Fes we de swel, akni
- Di ia we de gro na di bɔdi
- I izi fɔ mek pɔsin brus
- Dayabitis (dayabitis) ɔr de wɔs if i de
- Di ay blɔd prɛshɔn
- Katarakt ɔ glaukoma kɔndishɔn
- Ɔstioporosis we pɔsin kin gɛt
Ɔda mɛrɛsin dɛn we de mek yu jɔyn pen (Sulfasalazine ɛn Methotrexate) .
If, apat frɔm yu bak pen, yu gɛt pen bak na ɔda jɔyn dɛn, lɛk yu sholda, yu an, ɛn yu fut, yu dɔktɔ kin tɛl yu fɔ tek dɛn mɛrɛsin ya.
Sulfasalazine (Azulfidine): Dis na wan pil. Sɔm sayd ɛfɛkt nɔ kin apin so ɔltɛm, bɔt sɔm pipul dɛn kin gɛt fiva, nɔs, skin rɔsh, ɛn ed kin at.
Methotrexate: Dɛn kin tek dis as pil ɔ as injɛkshɔn . We yu de tek dis mɛrɛsin, yu dɔktɔ kin se yu fɔ tek di vaytamɛn fɔlik asid fɔ ridyus di sayd ɛfɛkt dɛn. Di sayd ɛfɛkt dɛn kin bi fɔ mek yu nɔs, yu mɔt de sɔfa, ɛn yu taya.
Wetin fɔ du if di sayd ɛfɛkt dɛn apin?
Dis na di pat we impɔtant pas ɔl. If yu gɛt ɛni chenj ɔ diskɔmfɔt na yu bɔdi bikɔs ɔf di mɛrɛsin we yu de tek, di fɔs ɛn bɛst tin fɔ du na fɔ tɛl yu dɔktɔ.
Nɔ ɛva stɔp fɔ tek yu mɛrɛsin ɔ chenj di doz fɔ yusɛf. If yu du dat, dat kin mek yu sik wɔs wantɛm wantɛm.
We yu tɛl yu dɔktɔ bɔt dis, i kin:
- Ridyus di doz we yu de tek di mɛrɛsin.
- Switch to ɔda mɛrɛsin we fit yu.
- Gi ɔda ɔda mɛrɛsin fɔ kɔntrol di sayd ɛfɛkt.
Fɔ ɛgzampul, if yu gɛt bɛlɛ we de at bikɔs ɔf wan NSAID, yu dɔktɔ kin gi yu ɔda mɛrɛsin we go protɛkt yu bɛlɛ di sem tɛm. So, nɔ fred fɔ tɔk to yu dɔktɔ bɔt ɔl dis opin wan. Yu ɛn yu dɔktɔ go ebul fɔ fɛn di tritmɛnt plan we go wok fɔ yu ɛn we nɔ go gɛt bɛtɛ sayd ɛfɛkt.
Mɛsej we dɛn kin kɛr go na os
- Ankylosing spondylitis mɛrɛsin kin mek yu gɛt sayd ɛfɛkt, bɔt dɛn nɔ kin apin to ɔlman. So nɔ fred we yu nɔ nid fɔ fred.
- If yu gɛt ɛni nyu sayn ɔr yu nɔr fil fayn bikɔs ɔf di mɛrɛsin we yu de tek, tɛl yu dɔktɔ wantɛm wantɛm.
- Nɔ stɔp fɔ tek mɛrɛsin ɔ chenj di doz fɔ ɛni rizin we yu nɔ go to yu dɔktɔ.
- Fɔ fɛn di mɛrɛsin wae go woke fayn fɔ yu ɛn wae nɔr gɛt bɔrku sayd ɛfɛkt na joyn wae yu ɛn yu dɔktɔ go tek togɛda. I kin tek sɔm tɛm.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt